76.48

2.31% -1.81

After Hours: 76.48

Ani Pharmaceuticals Inc (ANIP)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Ani Pharmaceuticals Inc stock is traded at $76.48, with a volume of 229.77K. It is down -2.31% in the last 24 hours and up +8.50% over the past month. ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Previous Close:

$78.29

Open:

$78.29

24h Volume:

229.77K

Relative Volume:

0.55

Market Cap:

$1.74B

Revenue:

$883.37M

Net Income/Loss:

$71.37M

P/E Ratio:

22.82

EPS:

3.3516

Net Cash Flow:

$150.90M

1W Performance:

-3.20%

1M Performance:

+8.50%

6M Performance:

-15.12%

1Y Performance:

+9.96%

1-Day Range:

$75.88

$78.46

1-Week Range:

$75.88

$80.79

52-Week Range:

$56.71

$99.50

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name

Ani Pharmaceuticals Inc

Sector

Healthcare (1112)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(218) 634-3500

Address

210 MAIN STREET WEST, BAUDETTE, MN

Employee

970

Twitter

Next Earnings Date

2026-02-27

Latest SEC Filings

ANIP's Discussions on Twitter

Compare ANIP vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ANIP Ani Pharmaceuticals Inc	76.48	1.78B	883.37M	71.37M	150.90M	3.3516
TAK Takeda Pharmaceutical Co Adr	17.85	56.39B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	120.76	50.93B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.66	43.19B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.61	36.99B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	577.58	25.36B	3.18B	1.33B	1.04B	27.90

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-10-25	Initiated	H.C. Wainwright	Buy
Mar-14-25	Initiated	Jefferies	Buy
Mar-12-25	Initiated	JP Morgan	Overweight
Dec-11-24	Initiated	Leerink Partners	Outperform
Oct-11-24	Initiated	Piper Sandler	Overweight
Mar-15-24	Initiated	CapitalOne	Overweight
Aug-22-23	Reiterated	H.C. Wainwright	Buy
Mar-01-23	Initiated	Guggenheim	Buy
Sep-07-22	Initiated	H.C. Wainwright	Buy
Nov-02-21	Initiated	Truist	Buy
May-07-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-12-19	Initiated	Guggenheim	Buy
May-10-19	Downgrade	Raymond James	Strong Buy → Outperform
Oct-16-17	Reiterated	Canaccord Genuity	Buy
Jul-31-17	Initiated	Canaccord Genuity	Buy
Feb-22-17	Downgrade	ROTH Capital	Buy → Neutral
Jun-23-16	Initiated	Raymond James	Strong Buy
May-24-16	Downgrade	Standpoint Research	Buy → Hold
Nov-13-15	Initiated	Standpoint Research	Buy
Sep-28-15	Upgrade	ROTH Capital	Neutral → Buy
Aug-05-15	Reiterated	Oppenheimer	Outperform
Aug-04-15	Reiterated	ROTH Capital	Neutral
Jul-31-15	Reiterated	Oppenheimer	Outperform
Jul-15-15	Reiterated	ROTH Capital	Neutral
Jun-23-15	Reiterated	Oppenheimer	Outperform
May-18-15	Reiterated	ROTH Capital	Neutral
May-06-15	Reiterated	Oppenheimer	Outperform
Apr-10-15	Downgrade	ROTH Capital	Buy → Neutral
Feb-26-15	Reiterated	ROTH Capital	Buy
Feb-18-15	Reiterated	Oppenheimer	Outperform

View All

Ani Pharmaceuticals Inc Stock (ANIP) Latest News

10:07 AM

ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules - MSN

10:07 AM

Apr 14, 2026

ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules - Intellectia AI

Apr 14, 2026

ANI Pharmaceuticals launches generic carbamazepine capsules By Investing.com - Investing.com India

Apr 14, 2026

Apr 13, 2026

Ani Pharmaceuticals’ Cook sells $38k in stock - Investing.com

Apr 13, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) VP Meredith Cook Sells 500 Shares - MarketBeat

Apr 13, 2026

Ani Pharmaceuticals’ Cook sells $38k in stock By Investing.com - Investing.com South Africa

Apr 13, 2026

ANI Pharmaceuticals (ANIP) SVP Meredith Cook sells 500 shares - Stock Titan

Apr 13, 2026

ANI Pharmaceuticals launches generic carbamazepine capsules - Investing.com

Apr 13, 2026

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules - Bitget

Apr 13, 2026

ANI Pharma targets $65M U.S. market with new Carbatrol generic - Stock Titan

Apr 13, 2026

Apr 11, 2026

Is ANI Pharmaceuticals Inc still a buy after recent gainsGDP Growth & Low Risk High Win Rate Picks - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results - TradingView — Track All Markets

Apr 10, 2026

Does ANI Pharmaceuticals' (ANIP) New Cardiovascular Generic Deepen Its Niche Strategy Or Stretch It? - Yahoo Finance

Apr 10, 2026

ANI Pharmaceuticals Expands Limited Competition Portfolio With New Cardiovascular Generic - Sahm

Apr 10, 2026

ANI Pharmaceuticals Looks Undervalued As Cortrophin Drives Rare Disease Growth - Seeking Alpha

Apr 10, 2026

ANIP Stock Price, Quote & Chart | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill

Apr 10, 2026

Apr 09, 2026

Record 2025 growth at ANI Pharmaceuticals (ANIP) and key 2026 proxy votes - Stock Titan

Apr 09, 2026

Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties - Yahoo Finance

Apr 09, 2026

Fed Watch: Can ANI Pharmaceuticals Inc lead its sector in growthWeekly Investment Summary & Verified Swing Trading Watchlist - baoquankhu1.vn

Apr 09, 2026

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet - Sahm

Apr 09, 2026

Did ILUVIEN’s NEW DAY Trial Publication Just Reframe ANI Pharmaceuticals' (ANIP) Retinal Franchise Narrative? - Sahm

Apr 09, 2026

ANI Pharmaceuticals launches generic isosorbide mononitrate tablets By Investing.com - Investing.com India

Apr 09, 2026

Apr 08, 2026